Nihon Kohden (OTCMKTS:NHNKY – Get Free Report) announced its quarterly earnings data on Thursday. The company reported $0.16 earnings per share for the quarter, Zacks reports. Nihon Kohden had a net margin of 7.78% and a return on equity of 9.28%.
Nihon Kohden Price Performance
NHNKY opened at $12.00 on Friday. Nihon Kohden has a 1 year low of $9.23 and a 1 year high of $17.28. The company has a market capitalization of $2.05 billion, a price-to-earnings ratio of 16.44 and a beta of 0.37. The firm’s fifty day moving average price is $11.01 and its two-hundred day moving average price is $11.41.
Analyst Upgrades and Downgrades
Separately, UBS Group upgraded Nihon Kohden from a “hold” rating to a “strong-buy” rating in a report on Monday, January 19th. One equities research analyst has rated the stock with a Strong Buy rating, Based on data from MarketBeat.com, Nihon Kohden presently has an average rating of “Strong Buy”.
Nihon Kohden Company Profile
Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.
The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.
Read More
- Five stocks we like better than Nihon Kohden
- Your Bank Account Is No Longer Safe
- When to buy gold (mathematically)
- Nervous about the stock market? Read this
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Nihon Kohden Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nihon Kohden and related companies with MarketBeat.com's FREE daily email newsletter.
